Analysis of genes to predict the effects of proprotein convertase subtilisin/kexin type 9-inhibitors and statins

<span class="paragraphSection"><strong>Commentary on ‘Variation in PCSK9 and HMGCR and Risk of Cardiovascular Disease and Diabetes’ by Ference BA<span style="font-style:italic;">et al</span>., N Engl J Med 2016.<a href="#cvx054-B1" class="reflinks"><sup>1</sup></a></strong></span>
Source: Cardiovascular Research - Category: Cardiology Source Type: research